NSE-CareEdge Ratings Launches PaRRVA for Investment Performance Verification

NSE-CareEdge Ratings has launched PaRRVA, a framework for investment performance verification. This initiative aims to enhance transparency and credibility in the securities market.

PaRRVA: A New Standard in Verification

PaRRVA, or Past Risk and Return Verification Agency, is a first-of-its-kind global initiative. It was conceptualised by SEBI in December 2025. The operational launch reaffirms SEBI’s commitment to fair and transparent markets.

Key Features of PaRRVA

PaRRVA validates risk-return metrics for Investment Advisors, Research Analysts, and Trading Members. It ensures greater credibility and compliance. The platform computes close to 50 different risk and return matrices from transaction data.

Benefits for Investors

Investors gain access to credible performance data. PaRRVA provides accurate, standardised, and unbiased disclosures. This helps in making informed decisions. The platform is now live at www.careparrva.com.

Commitment to Market Integrity

The launch of PaRRVA strengthens compliance. It prevents selective returns presentation and ensures every metric is backed by required disclosures. The secure data architecture maintains accuracy and speed.

As part of the PaRRVA initiative, NSE acts as the PaRRVA Data Centre (PDC). This collaboration enhances transparency and reliability in verification processes.

In conclusion, PaRRVA is poised to become a key enabler of transparent communication in the securities market. It promises to uphold market integrity and promote best practices.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of CARE Ratings Limited

CARE Ratings Limited belongs to the Financial Services › Financial Data & Stock Exchanges sector. Here’s a quick read on where the business and the stock stand today.

CARE holds in the upper half of its 52-week range, a sign the market backs the stock. Industry-leading margins of 35.6% reflect exceptional pricing power and operational efficiency. The business compounds revenue at 17.7% and profits at 22.3% CAGR. That is strong double-digit growth on both counts. The stock holds at 61% of its 52-week range with RSI at 61. In other words, neither side has a clear edge right now. Both the business and the stock move in the right direction. Revenue grows at 17.7%, profits at 22.3%, and the PEG sits at 1.39 — below its growth rate. That combination is rare.